4 Hot Small Caps To Watch After the Strong Jobs Report
Hot List Of Penny Stocks To Watch Right Now
This article was originally published by PennyStocks.
Penny Stocks, News, Momentum, Oh My!
When you’re looking for penny stocks to buy, news can play a big role. Just look at how recent economic data has impacted the market as a whole. The first full week of April has already gotten off to a great start. With major tech stocks like Facebook (NASDAQ: FB) and Google (NASDAQ: GOOGL) reaching record highs, investors are hoping for confidence in the state of the U.S. economy. A sizable amount of the bullish sentiment right now stems from last month’s solid job growth report.
Additionally, sentiment is positive as vaccinations in the U.S. and around the world continue. On Monday, the Dow closed with an over 374 point gain or 1.13%. Tom Essaye, the founder of Sevens Report Research, stated that “futures are modestly higher on momentum from Friday’s strong jobs report.”
[Learn More] What Are Penny Stocks & Should You Buy Them In 2021?
The report showed that the U.S. economy added more than 916,000 jobs in March, which is well over expectations of around 675,000. Additionally, unemployment rates fell to 6%, a sizable drop from 13% in March of last year. While fears of long-term inflationary effects on the U.S. economy are palpable, investors are showing confidence in the pandemic’s current state.
Hot Penny Stocks to Watch Right Now
This upbeat tone hopefully lasts for the foreseeable future. With Monday hopefully setting the stage for the next few months, investors are still searching for the best penny stocks to watch. And several companies showed big gains after recent news sparked momentum.
- Brooklyn ImmunoTherapeutics Inc. (NYSE: BTX)
- Weidai Ltd. (NYSE: WEI)
- NextDecade Corp. (NASDAQ: NEXT)
- Phunware Inc. (NASDAQ: PHUN)
Penny Stocks To Watch #1: Brooklyn ImmunoTherapeutics Inc.
Brooklyn ImmunoTherapeutics is a biopharmaceutical company working on cytokine-based therapies. It utilizes this unique therapy in the treatment of patients with various cancer types. Additionally, it is advancing its IRX-2 compound, which could have indications in use as a gene editing and cell therapy candidate.
Last month, BTX announced a reverse merger with NTN Buzztime Inc. CEO of Brooklyn, Ronald Guido, MS, MD Pharm, Med., stated that “we look forward to continuing to evaluate IRX-2, a human cell-derived IL-2 therapeutic in neoadjuvant and adjuvant treatment for advanced head and neck squamous cell cancer. IRX-2 has received both fast track designation and orphan drug designation from the FDA for its indiction with toppling results from our Phase 2B clinical trial expected in the first half of next year.”
One of the major value points of Brooklyn Therapeutics is its IRX-2 compound. Not many biotech companies can claim both fast track and orphan drug designation. This means that it could be close to commercialization if all goes according to plan.
While no company-specific news came out on Monday, April 5th, shares of BTX ended the day with a 19% gain. However, if you look at some of the recent filings, you can see the finer details. Multiple Form 3s were filed showing significant stakes in the company by officers and directors of Brooklyn Immuno. Following this, the company also announced Howard J. Federoff, M.D., Ph.D., as CEO. With new leadership and strong insider holdings, the market has taken these as big positives in April and could be something to keep in mind as the second quarter gets underway.
#2: Weidai Ltd.
Another large mover on Monday was Weidai Ltd. After hours, shares of WEI stock shot up by a very solid 21%. Again, no news specific to Weidai came out on Monday to underline this gain. But, to try and understand why it shot up, let’s take a closer look at Weidai.
A few weeks ago, the company announced its full-year 2020 financial results. For 2020, Weidai pulled in revenue of over $235 million. Additionally, the company reported a substantial net loss of $109.5 million. The growth of Weidai is largely based on what the financial market in China is doing. As an auto-backed financing solution prover in China, its success depends on its consumers’ financial situation. It offers these loans to provide credit to small and micro enterprises, connecting institutional funding to those wishing to borrow.
Read More
- 3 Top Penny Stocks For Your List If You Like Digital Entertainment
- 4 Penny Stocks For Your Tech Stock Watch List In April 2021
WEI has been known to make large intraday moves such as the one witnessed on April 5th. Since last October, shares of WEI are up by almost 70%. However, within that time frame, we also saw shares of WEI stock climb above $5. Considering its April 5th price of $1.40 or so, the recent surge has started turning heads. But without any apparent catalyst to point at, speculation and, in turn, high volatility could be factors to keep in mind with WEI.
#3: NextDecade Corp.
About a week ago, shares of NEXT stock dropped by as much as 15% during intraday trading. The fall came from an announcement that NextDecade would be raising a large sum of cash. As is usually the case, worries of market dilution when funding is announced can lead to a drop in price.
However, on April 5th, NEXT stock shot up by double digits. For some context, NextDecade is a liquified natural gas exporter in addition to its work in the carbon capture industry. The company plans to build a new export facility for LNG, including a carbon capture project. The development of this build-out is still in the very early stages, which explains the need to raise money through its proposed convertible preferred stock sale.
Because of this, there is a clear double-edged sword. The main value point for investors with NextDecade is the potential of this LNG and carbon capture project. But, in the meantime, the worry of dilution weighs heavy on investors’ minds. One thing to consider is its recent agreement with Occidental Petroleum (OXY) to develop a carbon dioxide transport and storage project in NextDecade’s Rio Grande Project in Texas.
The goal is to make this one of the greenest LNG projects by the time it is finished. While it does have many prospects in the works, it needs to begin executing on them to provide investors with confidence. But in the meantime, it could be worth giving a closer look.
#4: Phunware Inc. (NASDAQ: PHUN)
Another one of the companies grabbing attention right now is Phunware Inc. Unlike some of the other companies on this list of penny stocks, Phunware had news to reference. The company announced that its board authorized bitcoin purchases for its blockchain ecosystem launch. In particular, the launch of Phunware’s MaaS Customer Data Platform and MaaS Mobile Loyalty Ecosystem are set for release. The company also plans to debut its PhunWallet on iOS & Android later in April.
On top of this, the PhunWallet will manage the issuance of PhunCoin to reward consumers for the value of their data& PhunToken will be a reward for consumers in exchange for their engagement.
We recently completed an initial purchase of 25.8 bitcoin at an average price of $58,133 per bitcoin and are thrilled to actively participate in such a vibrant global market and community alongside Tesla, MicroStrategy, Square and many other corporations and funds worldwide.
Alan S. Knitowski, President, CEO and Co-Founder of Phunware
This adds to the recent progress made in the digital ecosystem. Phunware partnered with BitPay recently to expand its corporate benefits package to offer crypto payroll options for employees. In light of the excitement surrounding digital currency, tokenization, and blockchain tech, PHUN could be one of the penny stocks to watch right now.
The post 4 Hot Penny Stocks To Watch This Week After Strong Jobs Report appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
nasdaq stocks pandemic bitcoin blockchain crypto penny stocks cryptoUncategorized
Homes listed for sale in early June sell for $7,700 more
New Zillow research suggests the spring home shopping season may see a second wave this summer if mortgage rates fall
The post Homes listed for sale in…
- A Zillow analysis of 2023 home sales finds homes listed in the first two weeks of June sold for 2.3% more.
- The best time to list a home for sale is a month later than it was in 2019, likely driven by mortgage rates.
- The best time to list can be as early as the second half of February in San Francisco, and as late as the first half of July in New York and Philadelphia.
Spring home sellers looking to maximize their sale price may want to wait it out and list their home for sale in the first half of June. A new Zillow® analysis of 2023 sales found that homes listed in the first two weeks of June sold for 2.3% more, a $7,700 boost on a typical U.S. home.
The best time to list consistently had been early May in the years leading up to the pandemic. The shift to June suggests mortgage rates are strongly influencing demand on top of the usual seasonality that brings buyers to the market in the spring. This home-shopping season is poised to follow a similar pattern as that in 2023, with the potential for a second wave if the Federal Reserve lowers interest rates midyear or later.
The 2.3% sale price premium registered last June followed the first spring in more than 15 years with mortgage rates over 6% on a 30-year fixed-rate loan. The high rates put home buyers on the back foot, and as rates continued upward through May, they were still reassessing and less likely to bid boldly. In June, however, rates pulled back a little from 6.79% to 6.67%, which likely presented an opportunity for determined buyers heading into summer. More buyers understood their market position and could afford to transact, boosting competition and sale prices.
The old logic was that sellers could earn a premium by listing in late spring, when search activity hit its peak. Now, with persistently low inventory, mortgage rate fluctuations make their own seasonality. First-time home buyers who are on the edge of qualifying for a home loan may dip in and out of the market, depending on what’s happening with rates. It is almost certain the Federal Reserve will push back any interest-rate cuts to mid-2024 at the earliest. If mortgage rates follow, that could bring another surge of buyers later this year.
Mortgage rates have been impacting affordability and sale prices since they began rising rapidly two years ago. In 2022, sellers nationwide saw the highest sale premium when they listed their home in late March, right before rates barreled past 5% and continued climbing.
Zillow’s research finds the best time to list can vary widely by metropolitan area. In 2023, it was as early as the second half of February in San Francisco, and as late as the first half of July in New York. Thirty of the top 35 largest metro areas saw for-sale listings command the highest sale prices between May and early July last year.
Zillow also found a wide range in the sale price premiums associated with homes listed during those peak periods. At the hottest time of the year in San Jose, homes sold for 5.5% more, a $88,000 boost on a typical home. Meanwhile, homes in San Antonio sold for 1.9% more during that same time period.
Metropolitan Area | Best Time to List | Price Premium | Dollar Boost |
United States | First half of June | 2.3% | $7,700 |
New York, NY | First half of July | 2.4% | $15,500 |
Los Angeles, CA | First half of May | 4.1% | $39,300 |
Chicago, IL | First half of June | 2.8% | $8,800 |
Dallas, TX | First half of June | 2.5% | $9,200 |
Houston, TX | Second half of April | 2.0% | $6,200 |
Washington, DC | Second half of June | 2.2% | $12,700 |
Philadelphia, PA | First half of July | 2.4% | $8,200 |
Miami, FL | First half of June | 2.3% | $12,900 |
Atlanta, GA | Second half of June | 2.3% | $8,700 |
Boston, MA | Second half of May | 3.5% | $23,600 |
Phoenix, AZ | First half of June | 3.2% | $14,700 |
San Francisco, CA | Second half of February | 4.2% | $50,300 |
Riverside, CA | First half of May | 2.7% | $15,600 |
Detroit, MI | First half of July | 3.3% | $7,900 |
Seattle, WA | First half of June | 4.3% | $31,500 |
Minneapolis, MN | Second half of May | 3.7% | $13,400 |
San Diego, CA | Second half of April | 3.1% | $29,600 |
Tampa, FL | Second half of June | 2.1% | $8,000 |
Denver, CO | Second half of May | 2.9% | $16,900 |
Baltimore, MD | First half of July | 2.2% | $8,200 |
St. Louis, MO | First half of June | 2.9% | $7,000 |
Orlando, FL | First half of June | 2.2% | $8,700 |
Charlotte, NC | Second half of May | 3.0% | $11,000 |
San Antonio, TX | First half of June | 1.9% | $5,400 |
Portland, OR | Second half of April | 2.6% | $14,300 |
Sacramento, CA | First half of June | 3.2% | $17,900 |
Pittsburgh, PA | Second half of June | 2.3% | $4,700 |
Cincinnati, OH | Second half of April | 2.7% | $7,500 |
Austin, TX | Second half of May | 2.8% | $12,600 |
Las Vegas, NV | First half of June | 3.4% | $14,600 |
Kansas City, MO | Second half of May | 2.5% | $7,300 |
Columbus, OH | Second half of June | 3.3% | $10,400 |
Indianapolis, IN | First half of July | 3.0% | $8,100 |
Cleveland, OH | First half of July | 3.4% | $7,400 |
San Jose, CA | First half of June | 5.5% | $88,400 |
The post Homes listed for sale in early June sell for $7,700 more appeared first on Zillow Research.
federal reserve pandemic home sales mortgage rates interest ratesGovernment
Survey Shows Declining Concerns Among Americans About COVID-19
Survey Shows Declining Concerns Among Americans About COVID-19
A new survey reveals that only 20% of Americans view covid-19 as "a major threat"…
A new survey reveals that only 20% of Americans view covid-19 as "a major threat" to the health of the US population - a sharp decline from a high of 67% in July 2020.
What's more, the Pew Research Center survey conducted from Feb. 7 to Feb. 11 showed that just 10% of Americans are concerned that they will catch the disease and require hospitalization.
"This data represents a low ebb of public concern about the virus that reached its height in the summer and fall of 2020, when as many as two-thirds of Americans viewed COVID-19 as a major threat to public health," reads the report, which was published March 7.
According to the survey, half of the participants understand the significance of researchers and healthcare providers in understanding and treating long COVID - however 27% of participants consider this issue less important, while 22% of Americans are unaware of long COVID.
What's more, while Democrats were far more worried than Republicans in the past, that gap has narrowed significantly.
"In the pandemic’s first year, Democrats were routinely about 40 points more likely than Republicans to view the coronavirus as a major threat to the health of the U.S. population. This gap has waned as overall levels of concern have fallen," reads the report.
More via the Epoch Times;
The survey found that three in ten Democrats under 50 have received an updated COVID-19 vaccine, compared with 66 percent of Democrats ages 65 and older.
Moreover, 66 percent of Democrats ages 65 and older have received the updated COVID-19 vaccine, while only 24 percent of Republicans ages 65 and older have done so.
“This 42-point partisan gap is much wider now than at other points since the start of the outbreak. For instance, in August 2021, 93 percent of older Democrats and 78 percent of older Republicans said they had received all the shots needed to be fully vaccinated (a 15-point gap),” it noted.
COVID-19 No Longer an Emergency
The U.S. Centers for Disease Control and Prevention (CDC) recently issued its updated recommendations for the virus, which no longer require people to stay home for five days after testing positive for COVID-19.
The updated guidance recommends that people who contracted a respiratory virus stay home, and they can resume normal activities when their symptoms improve overall and their fever subsides for 24 hours without medication.
“We still must use the commonsense solutions we know work to protect ourselves and others from serious illness from respiratory viruses, this includes vaccination, treatment, and staying home when we get sick,” CDC director Dr. Mandy Cohen said in a statement.
The CDC said that while the virus remains a threat, it is now less likely to cause severe illness because of widespread immunity and improved tools to prevent and treat the disease.
“Importantly, states and countries that have already adjusted recommended isolation times have not seen increased hospitalizations or deaths related to COVID-19,” it stated.
The federal government suspended its free at-home COVID-19 test program on March 8, according to a website set up by the government, following a decrease in COVID-19-related hospitalizations.
According to the CDC, hospitalization rates for COVID-19 and influenza diseases remain “elevated” but are decreasing in some parts of the United States.
Government
Rand Paul Teases Senate GOP Leader Run – Musk Says “I Would Support”
Rand Paul Teases Senate GOP Leader Run – Musk Says "I Would Support"
Republican Kentucky Senator Rand Paul on Friday hinted that he may jump…
Republican Kentucky Senator Rand Paul on Friday hinted that he may jump into the race to become the next Senate GOP leader, and Elon Musk was quick to support the idea. Republicans must find a successor for periodically malfunctioning Mitch McConnell, who recently announced he'll step down in November, though intending to keep his Senate seat until his term ends in January 2027, when he'd be within weeks of turning 86.
So far, the announced field consists of two quintessential establishment types: John Cornyn of Texas and John Thune of South Dakota. While John Barrasso's name had been thrown around as one of "The Three Johns" considered top contenders, the Wyoming senator on Tuesday said he'll instead seek the number two slot as party whip.
Paul used X to tease his potential bid for the position which -- if the GOP takes back the upper chamber in November -- could graduate from Minority Leader to Majority Leader. He started by telling his 5.1 million followers he'd had lots of people asking him about his interest in running...
Thousands of people have been asking if I'd run for Senate leadership...
— Rand Paul (@RandPaul) March 8, 2024
...then followed up with a poll in which he predictably annihilated Cornyn and Thune, taking a 96% share as of Friday night, with the other two below 2% each.
????????️VOTE NOW ????️ ???? Who would you like to be the next Senate leader?
— Rand Paul (@RandPaul) March 8, 2024
Elon Musk was quick to back the idea of Paul as GOP leader, while daring Cornyn and Thune to follow Paul's lead by throwing their names out for consideration by the Twitter-verse X-verse.
I would support Rand Paul and suspect that other candidates will not actually run polls out of concern for the results, but let’s see if they will!
— Elon Musk (@elonmusk) March 8, 2024
Paul has been a stalwart opponent of security-state mass surveillance, foreign interventionism -- to include shoveling billions of dollars into the proxy war in Ukraine -- and out-of-control spending in general. He demonstrated the latter passion on the Senate floor this week as he ridiculed the latest kick-the-can spending package:
This bill is an insult to the American people. The earmarks are all the wasteful spending that you could ever hope to see, and it should be defeated. Read more: https://t.co/Jt8K5iucA4 pic.twitter.com/I5okd4QgDg
— Senator Rand Paul (@SenRandPaul) March 8, 2024
In February, Paul used Senate rules to force his colleagues into a grueling Super Bowl weekend of votes, as he worked to derail a $95 billion foreign aid bill. "I think we should stay here as long as it takes,” said Paul. “If it takes a week or a month, I’ll force them to stay here to discuss why they think the border of Ukraine is more important than the US border.”
Don't expect a Majority Leader Paul to ditch the filibuster -- he's been a hardy user of the legislative delay tactic. In 2013, he spoke for 13 hours to fight the nomination of John Brennan as CIA director. In 2015, he orated for 10-and-a-half-hours to oppose extension of the Patriot Act.
Among the general public, Paul is probably best known as Capitol Hill's chief tormentor of Dr. Anthony Fauci, who was director of the National Institute of Allergy and Infectious Disease during the Covid-19 pandemic. Paul says the evidence indicates the virus emerged from China's Wuhan Institute of Virology. He's accused Fauci and other members of the US government public health apparatus of evading questions about their funding of the Chinese lab's "gain of function" research, which takes natural viruses and morphs them into something more dangerous. Paul has pointedly said that Fauci committed perjury in congressional hearings and that he belongs in jail "without question."
Musk is neither the only nor the first noteworthy figure to back Paul for party leader. Just hours after McConnell announced his upcoming step-down from leadership, independent 2024 presidential candidate Robert F. Kennedy, Jr voiced his support:
Mitch McConnell, who has served in the Senate for almost 40 years, announced he'll step down this November.
— Robert F. Kennedy Jr (@RobertKennedyJr) February 28, 2024
Part of public service is about knowing when to usher in a new generation. It’s time to promote leaders in Washington, DC who won’t kowtow to the military contractors or…
In a testament to the extent to which the establishment recoils at the libertarian-minded Paul, mainstream media outlets -- which have been quick to report on other developments in the majority leader race -- pretended not to notice that Paul had signaled his interest in the job. More than 24 hours after Paul's test-the-waters tweet-fest began, not a single major outlet had brought it to the attention of their audience.
That may be his strongest endorsement yet.
-
Uncategorized3 weeks ago
All Of The Elements Are In Place For An Economic Crisis Of Staggering Proportions
-
Uncategorized1 month ago
Cathie Wood sells a major tech stock (again)
-
Uncategorized3 weeks ago
California Counties Could Be Forced To Pay $300 Million To Cover COVID-Era Program
-
Uncategorized2 weeks ago
Apparel Retailer Express Moving Toward Bankruptcy
-
Uncategorized4 weeks ago
Industrial Production Decreased 0.1% in January
-
International3 days ago
Walmart launches clever answer to Target’s new membership program
-
International3 days ago
EyePoint poaches medical chief from Apellis; Sandoz CFO, longtime BioNTech exec to retire
-
Uncategorized3 weeks ago
RFK Jr: The Wuhan Cover-Up & The Rise Of The Biowarfare-Industrial Complex